Colgate Palmolive (CL) Liabilities and Shareholders Equity (2009 - 2026)
Colgate Palmolive (CL) posted Liabilities and Shareholders Equity of $16.8 billion for Q2 2026, up 1.08% on a QoQ basis from $16.6 billion in Q1 2026, and down 3.89% year-over-year from $17.5 billion in Q2 2025.
Analysis
Colgate Palmolive (CL) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Colgate Palmolive has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $16.8 billion in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 3.89% year-over-year to $16.8 billion in Q2 2026; TTM through Jun 2026 was $67.2 billion, a 0.46% change from a year earlier, with the FY2025 full-year figure at $16.3 billion, up 1.77% from the prior year.
- Liabilities and Shareholders Equity was $16.8 billion for Q2 2026 at Colgate Palmolive, up from $16.6 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $17.5 billion in Q3 2025, with the low at $15.7 billion in Q2 2022.
- Average Liabilities and Shareholders Equity over 5 years is $16.4 billion, with a median of $16.4 billion recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity rose 6.01% in 2025, then dropped 3.89% in 2026.
- Over 5 years, Liabilities and Shareholders Equity stood at $15.7 billion in 2022, then advanced by 4.21% to $16.4 billion in 2023, then dropped by 2.12% to $16.0 billion in 2024, then advanced by 1.77% to $16.3 billion in 2025, then climbed by 2.82% to $16.8 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $16.8 billion (Q2 2026), $16.6 billion (Q1 2026), and $16.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.76 Bn | 69.72 Bn | 3.30 Bn | 16.79 Bn |
| 2 | Kenvue | 35.95 Bn | 34.84 Bn | 2.30 Bn | 26.74 Bn |
| 3 | Kimberly Clark | 34.91 Bn | 34.08 Bn | 1.60 Bn | 18.55 Bn |
| 4 | Bath & Body Works | 3.94 Bn | 3.15 Bn | 692.00 Mn | 5.16 Bn |
| 5 | Prestige Consumer Healthcare | 2.94 Bn | 2.87 Bn | - | 3.49 Bn |
| 6 | Perrigo | 2.07 Bn | 1.67 Bn | 313.90 Mn | 7.61 Bn |
| 7 | Edgewell Personal Care | 1.33 Bn | 933.73 Mn | 242.50 Mn | 3.54 Bn |
| 8 | Herbalife | 1.30 Bn | 935.57 Mn | 1.03 Bn | 2.86 Bn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | 4.66 Mn |
| 10 | Honest Company | 682.25 Mn | 576.35 Mn | 40.36 Mn | 220.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.79 Bn |
| Mar 31, 2026 | 16.61 Bn |
| Dec 31, 2025 | 16.33 Bn |
| Sep 30, 2025 | 17.51 Bn |
| Jun 30, 2025 | 17.47 Bn |
| Mar 31, 2025 | 16.65 Bn |
| Dec 31, 2024 | 16.05 Bn |
| Sep 30, 2024 | 16.77 Bn |
| Jun 30, 2024 | 16.48 Bn |
| Mar 31, 2024 | 16.57 Bn |
| Dec 31, 2023 | 16.39 Bn |
| Sep 30, 2023 | 16.04 Bn |
| Jun 30, 2023 | 16.23 Bn |
| Mar 31, 2023 | 16.17 Bn |
| Dec 31, 2022 | 15.73 Bn |
| Sep 30, 2022 | 16.29 Bn |
| Jun 30, 2022 | 15.71 Bn |
| Mar 31, 2022 | 15.72 Bn |
| Dec 31, 2021 | 15.04 Bn |
| Sep 30, 2021 | 15.88 Bn |